Search results
Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 7 days agoIntellia Therapeutics (NTLA) delivered earnings and revenue surprises of 21.48% and 85.43%,...
Earnings call: Intellia Therapeutics reports robust Q1 progress By Investing.com
Investing.com· 6 days agoIntellia Therapeutics (NASDAQ: NASDAQ:NTLA) has made significant progress in the first quarter of...
Earnings Beat: Intellia Therapeutics, Inc. (NASDAQ:NTLA) Just Beat Analyst Forecasts, And Analysts...
Simply Wall St. via Yahoo Finance· 4 days agoIntellia Therapeutics, Inc. (NASDAQ:NTLA) just released its quarterly report and things are looking...
Analyst Report: Intellia Therapeutics, Inc.
Morningstar Research via Yahoo Finance· 1 day agoIntellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly ...
Intellia Therapeutics First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 6 days agoIntellia Therapeutics (NASDAQ:NTLA) First Quarter 2024 Results Key Financial Results Revenue:...
Potential Price Increase for Intellia Therapeutics Inc
Knox Daily· 2 days agoIn a filing, Intellia Therapeutics Inc revealed its EVP, General Counsel BASTA JAMES unloaded Company’s shares for reported $75778.0 on Mar 04 ’24. In the ...
New York State Common Retirement Fund Acquires 4,765 Shares of Intellia Therapeutics, Inc....
ETF DAILY NEWS· 6 days agoNew York State Common Retirement Fund increased its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 9.6% in the fourth ...
Intellia Therapeutics, Inc. (NTLA) Just Overtook the 50-Day Moving Average
Zacks via Yahoo Finance· 2 days agoFrom a technical perspective, Intellia Therapeutics, Inc. (NTLA) is looking like an interesting...
Intellia Therapeutics Q1 2024 Earnings: Aligns with Analyst Projections Amidst Strategic Advances
GuruFocus.com via Yahoo Finance· 5 days agoOn May 9, 2024, Intellia Therapeutics Inc (NASDAQ:NTLA) disclosed its first quarter financial results through an 8-K filing, revealing a strategic progression ...
Q1 2024 Intellia Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoParticipants Ian Karp; Head-IR & Corporate Communications; Intellia Therapeutics Inc. John Leonard; President, Chief Executive Officer, Director;
